222. 一次性ネフローゼ症候群 Primary nephrotic syndrome Clinical trials / Disease details

臨床試験数 : 310 / 薬物数 : 295 - (DrugBank : 117) / 標的遺伝子数 : 63 - 標的パスウェイ数 : 194

1 trial found

diseases per page:

Showing 1 to 1 of 1 diseases

Filter by

No.	TrialID	Date_ enrollment	Date_ registration	Public_title	Scientific_title	Condition	Intervention	Primary_ sponsor	Secondary_ sponsor	Recruitment_ Status	Inclusion_ agemin	Inclusion_ agemax	Inclusion_ gender	Target_ size	Phase	Countries
1	NCT02000440 (ClinicalTrials.gov)	July 1, 2014	27/11/2013	A Phase II, Repeat Dose, Proof of Mechanism Study of Losmapimodto Reduce Proteinuria in Patients Wit ...	Study of Losmapimod to Reduce Proteinuria in Idiopathic Focal Segmental Glomerulosclerosis (FSGS)	Glomerulosclerosis, Focal Segmental	Drug: Losmapimod	GlaxoSmithKline	NULL	Completed	18 Years	70 Years	All	17	Phase 2	United States;Canada

First Previous1Next Last